Nuwellis (NASDAQ:NUWE) Shares Up 2.4% – Still a Buy?

Nuwellis, Inc. (NASDAQ:NUWE) shot up 2.4% on Friday . The company traded as high as $1.30 and last traded at $1.27. 126,201 shares changed hands during trading, a decline of 87% from the average session volume of 954,360 shares. The stock had previously closed at $1.24.

Nuwellis Stock Performance

The firm has a fifty day simple moving average of $1.17 and a 200-day simple moving average of $1.54. The company has a market capitalization of $5.55 million, a PE ratio of -0.01 and a beta of 0.31.

Nuwellis (NASDAQ:NUWE) last issued its quarterly earnings results on Monday, November 11th. The company reported $1.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.88) by $2.62. Nuwellis had a negative net margin of 169.54% and a negative return on equity of 28,159.25%. The business had revenue of $2.37 million during the quarter, compared to analyst estimates of $2.40 million. During the same quarter in the previous year, the firm earned ($63.29) earnings per share. As a group, research analysts anticipate that Nuwellis, Inc. will post -8.17 EPS for the current fiscal year.

About Nuwellis

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.